Quick summary: AneurysmFlow. Reason: Performance. Category: General hospital and personal use. Date: 2026-04-02.
AneurysmFlow
2026-04-02
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: AneurysmFlow. Reason: Performance. Category: General hospital and personal use. Date: 2026-04-02.
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
Affected products
Issue
Philips has determined that the mafa ratio does not provide reliable prognostic information regarding aneurysm occlusion following flow diverter stent treatment. the instructions for use (IFU) of AneurysmFlow state that the mafa ratio should not be used for making clinical decisions (section 9.2 measuring flow). In addition, when hovering over the mafa ratio header within the software interface, an on-screen message states that the mafa ratio is not to be used for clinical decision making. despite the existing cautions, the displayed mafa ratio may still be considered during intraprocedural decision-making and could influence clinical judgment. This may potentially result in an incorrect clinical decision.
What you should do
- Contact the manufacturer if you require additional information.
Additional official information
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.